Mayo Clinic Jun 1 2025 Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have lagged. Now, new research led by Mayo Clinic Comprehensive Cancer Center found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer - and with a specific genetic makeup called deficient DNA mismatch repair (dMMR) - was

Tag-uri: DNA